Form 4: cbdMD Director Kevin Roe Converts Preferred Stock to Common Stock

Director Kevin Roe converted preferred stock to common stock in cbdMD, Inc. on May 6, 2025, following a reverse stock split.

Summary

• On May 6, 2025, Kevin Roe, a director of cbdMD, Inc., converted 14,500 shares of 8% Series A Cumulative Convertible Preferred Stock into 23,563 shares of common stock.
• The conversion was automatic and occurred at 4:01 p.m. Eastern Time.
• Each share of preferred stock converted into thirteen shares of common stock.
• This transaction took place following a one-for-8 reverse stock split of the company's common stock, which became effective on May 6, 2025, at 4:02 p.m. Eastern Time.
• The reporting person directly owns 23,563 shares of common stock after the reported transaction.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock conversion. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about an insider transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates a conversion of preferred stock to common stock, which can be part of a company's capital structure management.

Stakeholder Impact

• The conversion of preferred stock to common stock may dilute existing shareholders' equity.

Key Dates

Keywords

Form 4, Beneficial Ownership, Kevin Roe, cbdMD, YCBD, Stock Conversion, Preferred Stock, Common Stock, Director, Reverse Stock Split